Gevo director receives 70,000-share stock grant

Marsh Andrew reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Marsh Andrew reported acquisition or exercise transactions in this Form 4 filing.

Gevo, Inc. director Andrew Marsh received a grant of 70,000 shares of restricted common stock, awarded at $0.0000 per share as compensation. These shares vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date, if he remains in continuous service. Following this award, Marsh directly holds 343,669 shares of common stock.

Insider Trade Summary

Grant/Award: 70,000 shares

Grant/Award 1 txn

Insider Marsh Andrew

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	70,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 343,669 shares (Direct)

Footnotes (1)

1. F1. Represents restricted common stock that vests on the earlier to occur of (i) the next annual meeting of stockholders or (ii) the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer as of the vesting date.

Key Figures

Restricted stock grant: 70,000 shares Grant price: $0.0000 per share Shares held after grant: 343,669 shares +1 more

4 metrics

Restricted stock grant 70,000 shares Common Stock award on May 27, 2026

Grant price $0.0000 per share Awarded as equity compensation

Shares held after grant 343,669 shares Total direct holdings following transaction

Vesting trigger Next annual meeting or first anniversary Earlier of the two dates, subject to service

Key Terms

restricted common stock, continuous service, annual meeting of stockholders, grant, award, or other acquisition

4 terms

restricted common stock financial

"Represents restricted common stock that vests on the earlier to occur of"

Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.

continuous service financial

"provided that the reporting person remains in continuous service with the issuer"

annual meeting of stockholders financial

"the earlier to occur of (i) the next annual meeting of stockholders"

grant, award, or other acquisition financial

"transaction code description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Gevo (GEVO) report for Andrew Marsh?

Gevo reported that director Andrew Marsh received a grant of 70,000 shares of restricted common stock. The shares were awarded at $0.0000 per share as compensation and are subject to vesting conditions tied to time and continued service with the company.

What are the vesting terms of Andrew Marsh’s 70,000-share award at Gevo (GEVO)?

The 70,000 restricted shares vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date. Vesting requires that Andrew Marsh remain in continuous service with Gevo through the applicable vesting date under the award’s conditions.

How many Gevo (GEVO) shares does Andrew Marsh hold after this Form 4 transaction?

After the restricted stock grant, Andrew Marsh directly holds 343,669 shares of Gevo common stock. This total includes the newly awarded 70,000 restricted shares, which are subject to vesting based on the specified time-based and continuous-service conditions in the grant documentation.

Was Andrew Marsh’s Gevo (GEVO) stock award a market purchase or a compensation grant?

The Form 4 shows a compensation grant, not a market purchase. Andrew Marsh received 70,000 restricted common shares at $0.0000 per share, classified as a grant, award, or other acquisition, reflecting equity-based compensation rather than an open-market stock transaction.

Does Andrew Marsh’s Gevo (GEVO) stock grant involve any derivative securities or options?

The reported transaction involves non-derivative common stock only, specifically 70,000 restricted shares. The derivativeSummary section is empty, indicating no options, warrants, or other derivative securities are reported in this Form 4 for Andrew Marsh in connection with this grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 05:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marsh Andrew

(Last) (First) (Middle)

968 ALBANY SHAKER ROAD

(Street)

LATHAM NEW YORK 12110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gevo, Inc. [ GEVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	05/27/2026		A		70,000	A	$0	343,669	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted common stock that vests on the earlier to occur of (i) the next annual meeting of stockholders or (ii) the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer as of the vesting date.

Remarks:

	/s/ E. Cabell Massey, Attorney-in-Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)